Moneycontrol PRO
HomeNewsIndiaCoronavirus Mumbai update: Tata Institute expects 50% of city population to develop herd immunity by January

Coronavirus Mumbai update: Tata Institute expects 50% of city population to develop herd immunity by January

The TIFR team expects coronavirus herd immunity to increase gradually and the city to become fully operational by around November 1.

September 07, 2020 / 17:42 IST

According to a report submitted to the Brihanmumbai Municipal Corporation (BMC), nearly 75 percent of people living in slum pockets in Mumbai and 50 percent of those residing in non-slum pockets would develop antibodies by December or January.

The study, published by the Tata Institute of Fundamental Research (TIFR), however, has not considered the threat of reinfection, which has emerged as a concern after the first confirmed case of reinfection in India was reported in Bengaluru.

A private hospital has reported that a 27-year-old woman from Bengaluru tested positive again nearly a month after she was treated and discharged from the hospital.

Track this LIVE blog for all the latest updates on coronavirus pandemic

The TIFR simulations suggest that by December 2020 and January 2021, the prevalence (fraction of the population infected) can be seen to be stabilising close to 75 percent in slums and 50 percent in non-slums, according to a Times of India report.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“This stabilisation and high prevalence indicate that Mumbai city may have more or less reached herd immunity by then and further new infections in the city will be substantially reduced,” the paper added.

Explainer: Reaching herd immunity in a viral pandemic

Herd immunity refers to a large portion of a community developing a degree of immunity to a virus, thereby reducing person-to-person spread. As a result, the whole community gains protection, not just those who are immune.

In the report, the TIFR team has said that Mumbai should open up by 30 percent in September in terms of attendance in offices and capacity of transport systems. This could be increased to 50 percent in October, the Times of India reported.

“The city should be further opened up gradually and become fully operational by around November 1,” said Dr Sandeep Juneja, Dean of School of Technology and Computer Science in TIFR.

"Our key observations are the second wave of hospitalisations and critical cases are much higher with the September 16th opening compared to the November 1 opening,” the report said.

On September 6 Mumbai saw the record spike of 1,910 new cases, taking its tally to 1,55,622. With 37 deaths, the toll in the city reached 7,869. The Mumbai Metropolitan Region (MMR), including Mumbai, added 5,407 new cases to its tally at 3,61,799. With 85 casualties, the cumulative toll mounted to 13,309 in the MMR.

India's COVID-19 tally of cases went past 42 lakh with a record 90,802 people being infected in a day.

Click here for Moneycontrol's full coverage of the COVID-19 outbreak

Moneycontrol News
first published: Sep 7, 2020 05:41 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347